Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic Cohort
The LIPAD Study Group
Institute of Neurogenetics
Clinic of Neurology
Clinic of Psychiatry and Psychotherapy
Centogene AG
Gertrudis Clinic Biskirchen
Parkinson-Center
Koç University
Sisli Etfal Training and Research Hospital
University of Luxembourg
University of Kiel
Neurologisches Fachkrankenhaus für Bewegungsstörungen / Parkinson
Parkinson's Disease and Movement Disorder Center of Boca Raton
Department of Neurology and Experimental Neurology
Charite - Universitatsmedizin Berlin
Paracelsus- Elena- Klinik Kassel
Department of Neurology
University of Marburg
University of Dundee School of Medicine
University of Pavia
Azienda Unità Sanitaria Locale – IRCCS di Reggio Emilia
University of Würzburg
University Hospital Hamburg-Eppendorf
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic Cohort'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Kinase
100%
Phosphotransferase
100%
Leucine-Rich Repeat
100%
Penetrance
37%
Sleep Quality
12%
Blood Plasma
12%
Comorbidity
12%
LRRK2
12%
Odor Recognition Test
12%
Immunocompetent Cell
12%
DNA RNA Hybridization
12%
Normal Human
12%
Autosomal Dominant Inheritance
12%
Self Concept
12%
Somnolence
12%
Medicine and Dentistry
Parkinson's Disease
100%
Leucine Rich Repeat Kinase 2
100%
Penetrance
21%
Hospital Anxiety and Depression Scale
7%
Physical Disease by Body Function
7%
DNA RNA Hybridization
7%
Autosomal Dominant Inheritance
7%
Self Concept
7%
Household
7%
Montreal Cognitive Assessment
7%
Immunocompetent Cell
7%
Stereotypic Movement Disorder
7%
Comorbidity
7%